NKure Therapeutics

Private

NKURE THERAPEUTICS PRIVATE LIMITED

Private

NKURE THERAPEUTICS PRIVATE LIMITED

2021

Founded in 2021, NKure Therapeutics operates in Health Tech industry. Initially, the company focused on developing advanced therapies for unmet medical needs targeting oncology and rare genetic disord...

Funding stage:

Seed

Last funding:

10/03/2024

Total funding:

$740.00K+

Revenue:

₹28.5 Lakh+ (FY25)

Prev. FY

Investors

Employee count:

Last 90d

Web traffic:

210

Last 30d

NKure Therapeutics: Financial Breakdown

Decoding financial health metrics of NKure Therapeutics

Total Revenue
₹28.5 Lakh
86%
Prev. FY
Total Expenses
₹5.8 Cr
35%
Prev. FY
Profit After Tax
₹-5.6 Cr
-35%
Prev. FY
Total Assets
₹17.5 Cr
103%
Prev. FY

Note: Above mentioned stats are for FY24-25

FAQs on Financials of NKure Therapeutics

No. In FY25, NKure Therapeutics reported a net loss of ₹5.6 Cr, so it was not profitable.

NKure Therapeutics's revenue grew 86.7% year-on-year, from ₹15.2 Lakh in FY24 to ₹28.5 Lakh in FY25.

In FY25, NKure Therapeutics posted revenue of ₹28.5 Lakh (up 86.7% YoY) and a net loss of ₹5.6 Cr. Explore the full financials of NKure Therapeutics here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

NKure Therapeutics - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

NKure Therapeutics: Financial Breakdown

FAQs on Financials of NKure Therapeutics

Is NKure Therapeutics profitable?

What is NKure Therapeutics's growth rate?

How is NKure Therapeutics's business performing?

Disclaimer